HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kitzmiller, J. L. Articles by Taslimi, M. M. Search for Related Content PubMed PubMed Citation Articles by Kitzmiller, J. L. Articles by Taslimi, M. M. Social Bookmarking                What's this?

Gestational Diabetes After Delivery

Short-term management and long-term risks

¹ Division of Maternal-Fetal Medicine, Santa Clara County Health System, San Jose, California
² California Diabetes and Pregnancy Program, Stanford, California
³ Department of Obstetrics and Gynecology, Stanford University Medical School, Stanford, California

Address correspondence and reprint requests to John L. Kitzmiller, MD, Santa Clara Valley Health System, PEP Services, Suite 340, 750 S. Bascom Ave., San Jose, CA 95128. E-mail: kitz@batnet.com

Abbreviations: CVD, cardiovascular disease • FPG, fasting plasma glucose • GDM, gestational diabetes mellitus • GTT, glucose tolerance test • hsCRP, highly sensitive C-reactive protein • IFG, impaired fasting glucose • IGT, impaired glucose tolerance

The first 300 words of the full text of this article appear below.

	INTRODUCTION

 
After the intensified treatment often required for treating gestational diabetes mellitus (GDM), clinicians may be tempted to relax after delivery of the baby. If it is assumed that no further management is needed, an excellent opportunity to improve the future health status of these high-risk women may be lost. There are special concerns for the early postpartum care of women with GDM. Encouragement and facilitation of exclusive breastfeeding is very important because of the profound short-term as well as long-term health benefits to the infant and the reduced risks for subsequent obesity and glucose intolerance demonstrated in many breastfeeding women. A method of contraception should be chosen that does not increase the risk of glucose intolerance in the mother. Some women with GDM will have persisting hyperglycemia in the days after delivery that will justify medical management for diabetes and perhaps for hypertension, microalbuminuria, and dyslipidemia. Treatment should be maintained according to the guidelines of the American Diabetes Association and other relevant organizations and adjusted for the needs of lactation. Treatment should be continued in adequate fashion to minimize risks to the early conceptus if there is a subsequent planned or unplanned pregnancy.

Most women with GDM will not have severe hyperglycemia after delivery. This group should be followed for at least 6–12 weeks to determine their glucose status. Many studies over 3 decades on all continents of the globe demonstrate the high risk of subsequent diabetes in this female population. The degree of this risk is best assessed by glucose tolerance testing. Randomized controlled trials have proven that several interventions (diet and planned exercise 30–60 min daily at least 5 days per week and antidiabetic medications) can significantly delay or prevent the appearance of type 2 diabetes in the women with impaired glucose tolerance (IGT). The high-risk women can . . . [Full Text of this Article]

	EARLY POSTPARTUM CARE—

 

	POSTPARTUM GLUCOSE TESTING—

 

	CURRENT STUDY: FAILURE OF FPG TO IDENTIFY CASES OF IGT OR TYPE 2 DIABETES 6–21 WEEKS AFTER PREGNANCY IN A MULTIETHNIC POPULATION—

 

	MANAGEMENT OF IGT AFTER PREGNANCY—

 

	CARDIOVASCULAR RISKS IN WOMEN WITH PRIOR GDM—

 

	CONCLUSIONS—

 

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L. L. Exelbert A Comparison Between a "Terror" Reaction and a "Nonchalant" Reaction to the Diagnosis of Gestational Diabetes Clin. Diabetes, October 1, 2008; 26(4): 177 - 178. [Full Text] [PDF]